{"version":1,"type":"story","url":"https://digestai.news/story/basecamp-research-raises-140m-series-c-led-by-s32","json":"https://digestai.news/story/basecamp-research-raises-140m-series-c-led-by-s32.json","markdown":"https://digestai.news/story/basecamp-research-raises-140m-series-c-led-by-s32.md","slug":"basecamp-research-raises-140m-series-c-led-by-s32","headline":"Basecamp Research raises $140M Series C led by S32","summary":"London-based AI life sciences startup Basecamp Research has secured $140m in a Series C funding round, bringing its total capital raised to $225m. The round was led by S32, a venture firm founded by Bill Maris, and included participation from Nvidia’s NVentures and Anthropic’s Anthology Fund. Other new investors include the NATO Innovation Fund, Rockefeller, and the UK government’s Sovereign AI Fund.\n\nFounded in 2019 by doctors Glen Gowers and Oliver Vince, Basecamp uses AI and biodiversity data to design treatments for cancer, autoimmune, and other diseases. The company plans to use the new funding to train next-generation AI models and advance its pipeline of AI-designed therapeutics. Its Eden models are currently being applied to in vivo cell therapy, which involves reprogramming a patient’s cells inside the body.\n\nBasecamp states that current cell therapies are limited by complexity and high manufacturing costs, often reaching hundreds of thousands of dollars per patient. By combining AI-designed DNA sequences with specialized enzymes, the company aims to make these therapies more sophisticated and easier to administer. The startup reports strong preclinical results and notes that its models are trained on a proprietary genomic dataset collected from partnerships in over 30 countries.","keyPoints":["Basecamp Research raised $140m in a Series C round led by S32.","Total funding reaches $225m with participation from Nvidia and Anthropic.","Funds will train new AI models and advance in vivo cell therapy pipeline."],"whyItMatters":"This significant investment highlights the growing intersection of frontier AI and biotech, potentially lowering the cost and complexity of advanced cell therapies for patients with limited treatment options.","category":{"slug":"business","name":"Business & Funding","url":"https://digestai.news/category/business"},"entities":{"companies":["Basecamp Research","S32","Nvidia","Anthropic","Menlo Ventures","GV"],"models":["Eden models"],"people":["Bill Maris","Glen Gowers","Oliver Vince","Joséphine Kant"]},"firstPublishedAt":"2026-09-23T13:25:20Z","updatedAt":"2026-09-23T13:52:23Z","sourceCount":2,"hasPrimarySource":false,"sources":[{"outlet":"tech.eu","title":"London-based AI life sciences startup Basecamp Research raised a $140M Series C led by S32, with participation from Anthropic, taking its total funding to $225M","url":"https://tech.eu/2026/09/23/anthropic-and-nvidia-back-basecamp-research-in-140m-series-c","publishedAt":"2026-09-23T13:25:20Z","type":"press","primary":false,"lead":true},{"outlet":"The Decoder","title":"Inside Basecamp Research, the AI startup turning evolution into training data","url":"https://the-decoder.com/inside-basecamp-research-the-ai-startup-turning-evolution-into-training-data","publishedAt":"2026-09-23T13:52:23Z","type":"press","primary":false,"lead":false}],"sourceNotes":null,"discussions":[],"thread":null,"cite":{"text":"Digest AI, \"Basecamp Research raises $140M Series C led by S32\", 23 September 2026, https://digestai.news/story/basecamp-research-raises-140m-series-c-led-by-s32","publisher":"Digest AI","title":"Basecamp Research raises $140M Series C led by S32","datePublished":"2026-09-23T13:25:20Z","url":"https://digestai.news/story/basecamp-research-raises-140m-series-c-led-by-s32"},"generatedBy":"Written by Digest AI's editorial model from the linked sources; the sources are the record.","license":"Headlines, digests and key points are written by Digest AI and may be quoted with a link to the story page. Linked articles belong to their publishers. Terms: https://digestai.news/terms#reuse"}